Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Date publication

janvier 2019

Journal

Clinical rheumatology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr LIOURE Bruno , Pr RUBIO Marie Thérèse , Pr MARTIN Thierry

Tous les auteurs :
Guillaume-Jugnot P, Badoglio M, Labopin M, Terriou L, Yakoub-Agha I, Martin T, Lioure B, Marjanovic Z, Blaise D, Nguyen S, Pugnet G, Huynh A, Deligny C, Seinturier C, Garban F, Swiader L, Bay JO, Braun T, de Latour RP, Rubio MT, Farge D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/30663016

Résumé

The use of autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease (AD) patients has increased progressively worldwide. We retrospectively analysed the long-term outcome of AHSCT for AD reported to the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Mots clés

Adult patients, Autoimmune disease, Autologous, Haematopoietic stem cell transplantation

Référence

Clin. Rheumatol.. 2019 Jan 21;: